AU545216B2 - 2-(4-benzylpiperidino)-1-(4 halo-phenyl)piopan-1-ol - Google Patents

2-(4-benzylpiperidino)-1-(4 halo-phenyl)piopan-1-ol

Info

Publication number
AU545216B2
AU545216B2 AU82555/82A AU8255582A AU545216B2 AU 545216 B2 AU545216 B2 AU 545216B2 AU 82555/82 A AU82555/82 A AU 82555/82A AU 8255582 A AU8255582 A AU 8255582A AU 545216 B2 AU545216 B2 AU 545216B2
Authority
AU
Australia
Prior art keywords
piopan
benzylpiperidino
halo
phenyl
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU82555/82A
Other languages
English (en)
Other versions
AU8255582A (en
Inventor
Jonathan Frost
Alexander Wick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of AU8255582A publication Critical patent/AU8255582A/en
Application granted granted Critical
Publication of AU545216B2 publication Critical patent/AU545216B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Artificial Filaments (AREA)
  • Lubricants (AREA)
AU82555/82A 1981-04-14 1982-04-13 2-(4-benzylpiperidino)-1-(4 halo-phenyl)piopan-1-ol Ceased AU545216B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8107445 1981-04-14
FR8107445A FR2503705A1 (fr) 1981-04-14 1981-04-14 Derives de phenethanolamine, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
AU8255582A AU8255582A (en) 1982-10-21
AU545216B2 true AU545216B2 (en) 1985-07-04

Family

ID=9257367

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82555/82A Ceased AU545216B2 (en) 1981-04-14 1982-04-13 2-(4-benzylpiperidino)-1-(4 halo-phenyl)piopan-1-ol

Country Status (20)

Country Link
US (1) US4430334A (de)
EP (1) EP0063084B1 (de)
JP (1) JPS57179160A (de)
AT (1) ATE9330T1 (de)
AU (1) AU545216B2 (de)
CA (1) CA1185604A (de)
DE (1) DE3260703D1 (de)
DK (1) DK154979C (de)
ES (1) ES511365A0 (de)
FI (1) FI821288L (de)
FR (1) FR2503705A1 (de)
GR (1) GR75543B (de)
HU (1) HU186492B (de)
IE (1) IE52877B1 (de)
IL (1) IL65493A (de)
MX (1) MX155561A (de)
NO (1) NO821192L (de)
NZ (1) NZ200275A (de)
PT (1) PT74744B (de)
ZA (1) ZA822489B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
FR2546166B1 (fr) * 1983-05-19 1985-10-25 Synthelabo Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
US4783471A (en) * 1985-07-02 1988-11-08 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine methanol derivatives and the uses thereof
US4912117A (en) * 1985-07-02 1990-03-27 Merrell Dow Pharmaceuticals Inc. Novel chemical compounds
FR2672286B1 (fr) * 1991-01-31 1994-11-18 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(phenylmethyl)piperidin-1-yl]ethanol, leur preparation et leur application en therapeutique.
FR2678269B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(2-phenylethyl)piperidin-1-yl]ethanol, leur application et leur preparation en therapeutique.
FR2696741B1 (fr) * 1992-10-12 1994-11-25 Synthelabo Dérivés de 1-(4-chlorophényl)-2-[4-[(4-fluorophényl)méthyl]piperidin-1-yl] éthanol, leur préparation et leur application en thérapeutique.
US20070048577A1 (en) * 2005-08-30 2007-03-01 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Naval Re Scalable microbial fuel cell with fluidic and stacking capabilities

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5733M (de) * 1966-09-27 1968-01-22
DE1618010A1 (de) * 1967-06-15 1970-11-05 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Aminoketonen
IE34545B1 (en) * 1969-10-01 1975-06-11 Continental Pharma Amino-alcohols,their salts and process for preparing the same
AT354187B (de) * 1976-11-22 1979-12-27 Hoffmann La Roche Fungizides mittel

Also Published As

Publication number Publication date
CA1185604A (en) 1985-04-16
FR2503705A1 (fr) 1982-10-15
PT74744B (fr) 1985-01-08
DK154979C (da) 1989-07-10
GR75543B (de) 1984-07-27
FR2503705B1 (de) 1983-11-04
US4430334A (en) 1984-02-07
JPS6124388B2 (de) 1986-06-10
FI821288A0 (fi) 1982-04-13
DK165282A (da) 1982-10-15
MX155561A (es) 1988-03-25
DK154979B (da) 1989-01-16
IE52877B1 (en) 1988-03-30
PT74744A (fr) 1982-05-01
EP0063084A1 (de) 1982-10-20
NZ200275A (en) 1984-07-06
ATE9330T1 (de) 1984-09-15
ES8304548A1 (es) 1983-03-01
JPS57179160A (en) 1982-11-04
AU8255582A (en) 1982-10-21
NO821192L (no) 1982-10-15
ZA822489B (en) 1983-02-23
HU186492B (en) 1985-08-28
FI821288L (fi) 1982-10-15
ES511365A0 (es) 1983-03-01
IE820869L (en) 1982-10-14
EP0063084B1 (de) 1984-09-12
DE3260703D1 (en) 1984-10-18
IL65493A (en) 1985-03-31
IL65493A0 (en) 1982-07-30

Similar Documents

Publication Publication Date Title
ZA813555B (en) 2-(halogenomethyl-phenyl)-4-halogeno-oxazole derivatives,a process for the preparation thereof,and radiation-sensitive compositions containing these derivatives
AU535320B2 (en) 2-(2-(1,4-benzodioxanyl))-2-imidazoling derivatives
AU545216B2 (en) 2-(4-benzylpiperidino)-1-(4 halo-phenyl)piopan-1-ol
AU548411B2 (en) Oxindole derivatives
DE3260334D1 (en) Vinyl azoles, process for their preparation and their application as fungicides
PH24207A (en) 2-acylamino-6-amino-4,5,6,7-tetrahydrobenzothiazoles
IE820199L (en) Dibenzofuran derivatives
ES8303412A1 (es) Procedimiento de obtencion de nuevas xantinas con actividad farmacologica
AU565221B2 (en) 2-(1,2,4-triazol-1-yl) propanone derivatives
ES509792A0 (es) "un procedimiento para preparar una composicion antipruritica".
GR74782B (de)
AU553493B2 (en) 3,7alpha-diazacyclohepta(j,k)fluoriene derivatives
EP0365913A3 (en) Substituted 2-aminothiazoles
ES512194A0 (es) "procedimiento de preparar compuestos piridotienopiridacinicos".
ES513889A0 (es) "procedimiento de producir derivados amidicos".
ES8307225A1 (es) Procedimiento para preparar 4-(2-aminoetiltiometil)-5-metilimidazol.
AU3338378A (en) (&,-)-cis -alpha-(3-(2,6-dimethyl-1-piperidinyl)-alpha-phenyl2-pyridinemethanol compounds
JPS52136109A (en) Unsaturated halo compound derivatives and their preparation
IE821627L (en) MICRONIZED 2-(4-CHLOROPHENYL)-s-TRIAZOLO¹£5,1-a|-ISOQUINOLINE ANTIFERTILITY FORMULATION
JPS52136163A (en) Novel 2-((3,5'-dimethoxy-4'-hydroxy)-phenylmethylene)-3-carboxy-4-(3",5"-demethoxy-4"-hydroxyphenyl)-gamma-butyrolactone
FI782961A (fi) Foerfarande foer framstaellning av 2-(2',2',2'-tribrometyl)-4-klorcyklobutan-1-oner
ES508389A0 (es) "procedimiento para producir derivados de flavona".
IT8124955A0 (it) Procedimento migliorato per lapreparazione di un derivato al 2,4-diossacicloesanone.